Zydus Lifesciences shares show bullish momentum, forming a weekly Inverted Head and Shoulders pattern with a breakout above ...

With the stock currently trading at Rs 991.15, Zydus Lifesciences has experienced a notable decline in today's session amid a surge in trading volume.

Zydus Lifesciences Limited announced the death of Mr. Samir Desai, President-BU Biologics, on August 26, 2025. His passing results in a change in the company's senior management.

As per the CRISIL Ra ng framework, the score between 61-70 is considered as 'strong'.

Agenus Inc. ("Agenus") (Nasdaq: AGEN), a leader in immuno-oncology, today announced an update to its virtual Stakeholder Briefing on August 27, 2025 at 4:00 p.m. ET which introduces a new virtual ...

Sharvil Patel emphasizes the importance of influenza vaccination for public health, urging timely vaccination to prevent ...

Zydus Lifesciences Limited has announced the passing away of Mr. Samir Desai, President-BU Biologics, a member of the company's Senior Management, effective August 26, 2025. The company has disclosed ...

Zydus Lifesciences' shares saw a 2.78% decline, dropping to Rs 994.70 in early trading on Tuesday. Despite this, the company's financial performance shows consistent growth.

Discover the distinguished Grand Jury for the India DigiPlus Awards 2025, showcasing top leaders in digital marketing who ...

Zydus Lifesciences Ltd is quoting at Rs 1009, up 2.04% on the day as on 12:49 IST on the NSE. The stock is down 8.97% in last one year as compared to a 0.08% drop in NIFTY and a 0.95% drop in the ...

Government measures such as interest rate cuts and proposed reduction in Goods and Services Tax (GST) could potentially boost ...